COVID-19 vaccination: invitations being sent to risk groups From 27 August 2024 on, the first people will receive an invitation for COVID-19 vaccination. RIVM will send the invitations to people aged 60 years and older.
New COVID-19 vaccination round for risk groups this autumn The new COVID-19 vaccination round will start on 16 September 2024. For people who are at higher risk, the COVID-19 vaccination offers more effective protection against hospital admission or death due to COVID-19.
New research portal for people with post-COVID Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.
Almost half of participants lost at least 5% of their weight after completing the CLI The percentage of participants (47%) that lost at least 5% of their weight was higher at the end of the entire CLI programme than in the first phase. This is shown by the latest RIVM report on the Combined Lifestyle Intervention (CLI).
Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.
Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
Air pollution increases risk of infection and severity of illness from COVID-19 People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.
RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.